Table 9.12b

Unadjusted Patient Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	852	92.7%	0.9%	852	86.6%	1.2%	609	77.7%	1.7%	167	77.8%	3.2%
Primary Diagnosis	Non-Cholestatic Cirrhosis	464	94.2%	1.1%	464	86.9%	1.6%	262	75.2%	2.7%	28	53.6%	9.4%
	Cholestatic Liver Disease/Cirrhosis	149	98.0%	1.2%	149	96.0%	1.6%	88	81.8%	4.1%	7	85.7%	13.2%
	Acute Hepatic Necrosis	42	81.0%	6.1%	42	69.0%	7.1%	41	65.9%	7.4%	13	92.3%	7.4%
	Biliary Atresia	77	87.0%	3.8%	77	85.7%	4.0%	93	87.1%	3.5%	85	85.9%	3.8%
	Metabolic Diseases	24	91.7%	5.6%	24	79.2%	8.3%	28	85.7%	6.6%	13	84.6%	10.0%
	Malignant Neoplasms	44	84.1%	5.5%	44	72.7%	6.7%	52	69.2%	6.4%	2	50.0%	35.4%
	Other	52	90.4%	4.1%	52	88.5%	4.4%	45	80.0%	6.0%	19	63.2%	11.1%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.